10/24/2024
8:10 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:15 PM | Cadrenal Therapeutics (Subject)
Havlickova 648 a.s. (Filed by)
| Form SC 13G | |
09/25/2024
3:05 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:03 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
5:03 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:02 PM | Cadrenal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:05 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/11/2024
4:25 PM | Cadrenal Therapeutics (Filer)
| Form DEF 14A | |
06/11/2024
4:27 PM | Cadrenal Therapeutics (Filer)
| Form ARS | |
05/29/2024
4:27 PM | Cadrenal Therapeutics (Filer)
| Form PRE 14A | |
05/09/2024
5:23 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2024
4:30 PM | Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
8:26 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/20/2024
11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/12/2024
7:37 AM | Cadrenal Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
7:04 AM | Cadrenal Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/11/2024
8:15 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:00 AM | Cadrenal Therapeutics (Filer)
| Form 8-K/A | |
02/14/2024
2:34 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cadrenal Therapeutics (Subject)
| Form SC 13G | |
02/12/2024
8:41 PM | Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
8:42 PM | Cadrenal Therapeutics (Subject)
Pham Quang X (Filed by)
| Form SC 13G | |
01/19/2024
6:38 PM | Cadrenal Therapeutics (Issuer)
LOSORDO DOUGLAS W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:38 PM | Cadrenal Therapeutics (Issuer)
WILSON GLYNN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:39 PM | Cadrenal Therapeutics (Issuer)
Szot Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:40 PM | Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:41 PM | Cadrenal Therapeutics (Issuer)
Lisicki Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:41 PM | Cadrenal Therapeutics (Issuer)
MURPHY JOHN RAYMOND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:41 PM | Cadrenal Therapeutics (Issuer)
Zelenkofske Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
8:15 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:00 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
